VRTX
#127
Vertex Pharmaceuticals Incorporated - Common Stock
476.3 1 USD
-0.01%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.82%
Variación mensual
+5.55%
Variación en los últimos 6 meses
+8.14%
Cambio anual
+2.41%
Cierres anteriores
480.2 5
Open
476.3 1
Mínimo
476.3 1
High
476.3 1
Volumen
395
Financials
- Market Capitalization 120.89 B
- Employee 6 400
- Founded 1989
- CEO Reshma Kewalramani
- Website www.vrtx.com
- Headquarter Massachusetts, United States
- FIGI BBG000C1S2X2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
26.5
Relación precio/flujo de caja
9.42
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 244 |  REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 656.12 USD | -1.05% | -1.94% | +6.50% | +19.28% | 68.79 B USD | ||
| 301 |  ARGX argenx SE - American Depositary Shares | 859.43 USD | -1.92% | -5.99% | -2.54% | +53.93% | 53.18 B USD | ||
| 375 |  RVMD Revolution Medicines, Inc. - Common Stock | 184.97 USD | +0.55% | -2.65% | +17.03% | +233.88% | 39.32 B USD | ||
| 387 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 281.26 USD | -2.36% | -11.69% | -2.38% | -9.64% | 37.55 B USD |